Skip to content
Application 071868
- Type
- ANDA
- Sponsor
- HOSPIRA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | CYTARABINE | CYTARABINE | INJECTABLE;INJECTION | 20MG/ML | No | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 61703-305 | Cytarabine | CYTARABINE | Hospira, Inc. | ANDA | Current |
| 61703-305 | Cytarabine | CYTARABINE | Hospira, Inc. | ANDA | Current |
| 61703-305 | Cytarabine | CYTARABINE | Hospira, Inc. | ANDA | Current |
| 61703-305 | Cytarabine | CYTARABINE | Hospira, Inc. | ANDA | Current |
| 61703-305 | Cytarabine | CYTARABINE | Hospira, Inc. | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 63712 | SUPPL | 2020-06-26 |